- Home
- ROIV vs NFG Comparison
ROIV vs NFG Comparison
Compare ROIV & NFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | NFG |
|---|---|---|
| Founded | 2014 | 1902 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 7.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | NFG |
|---|---|---|
| Price | $21.67 | $82.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | $21.94 | ★ $91.20 |
| AVG Volume (30 Days) | ★ 6.7M | 507.4K |
| Earning Date | 11-10-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | N/A | ★ 576.19 |
| EPS | N/A | ★ 5.68 |
| Revenue | $20,329,000.00 | ★ $2,277,541,000.00 |
| Revenue This Year | N/A | $22.37 |
| Revenue Next Year | $376.94 | $22.03 |
| P/E Ratio | ★ N/A | $14.48 |
| Revenue Growth | N/A | ★ 17.11 |
| 52 Week Low | $8.73 | $59.01 |
| 52 Week High | $22.45 | $94.13 |
Technical Indicators
Market Signals| Indicator | ROIV | NFG |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 53.39 |
| Support Level | $20.14 | $81.32 |
| Resistance Level | $21.48 | $83.85 |
| Average True Range (ATR) | 0.71 | 1.26 |
| MACD | 0.00 | 0.20 |
| Stochastic Oscillator | 65.96 | 64.60 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About NFG National Fuel Gas Company
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.